XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (7,605,505) $ (9,770,855)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 962,800 544,564
Loss on extinguishment of convertible notes payable 0 1,774,662
Gain on extinguishment of notes payable 0 (839,945)
Unrealized gain on change in fair value of the Common Warrants (2,540,700) 0
Stock-based compensation 2,245,749 1,631,175
Provision for bad debts 10,000 6,245
Change in operating assets and liabilities:    
Accounts receivable (64,928) (549,273)
Inventories 815,294 68,251
Prepaid expenses and other current assets and deposits (603,439) 242,882
Accounts payable and accrued liabilities 586,379 (1,525,355)
Deferred revenue 476,264 (258,229)
Net cash used in operating activities (5,718,086) (8,675,878)
Cash flows from investing activities:    
Purchase of property and equipment (246,892) (1,642,277)
Net cash used in investing activities (246,892) (1,642,277)
Cash flows from financing activities:    
Net proceeds from exercise of warrants 75 2,613,929
Net proceeds from issuance of common stock and warrants 4,091,833 13,756,507
Repayment of convertible notes 0 (1,665,581)
Net cash provided by financing activities 4,091,908 14,704,855
Net (decrease) increase in cash and cash equivalents (1,873,070) 4,386,700
Cash and cash equivalents at beginning of period 6,554,948 7,786,743
Cash and cash equivalents at end of period 4,681,878 12,173,443
Supplemental Disclosures of Cash Flow Information:    
Cash paid during period for interest 0 0
Cash paid during period for income taxes 0 0
Non-cash investing and financing activities:    
Interest paid in kind 0 28,329
Deemed dividend warrant modifications 110,105 0
Property and equipment acquired, and included in accounts payable 249,468 132,270
Issuance of stock options for payment of accrued bonus 300,000 0
Fair value of warrants issued $ 3,350,400 $ 1,074,118